BCTX - BriaCell Therapeutics Corp.
3.86
-0.150 -3.886%
Share volume: 188,426
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$4.01
-0.15
-0.04%
View ratios
| Fiscal Date | 01-31-2024 | 04-30-2024 | 07-31-2024 | 10-31-2024 | 01-31-2025 | 04-30-2025 | 07-31-2025 | 10-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 03-18-2024 | 06-14-2024 | 12-16-2024 | 12-16-2024 | 03-12-2025 | 06-16-2025 | 10-16-2025 | 12-11-2025 | |
| Cash flow financing | 0.000 | 0.000 | 4.419 M | 11.960 M | 5.217 M | 14.714 M | 13.557 M | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 293.251 K | 527.764 K | 0.000 | 0.000 | 0.000 | |
| Cash flow | 0.000 | 0.000 | -73.605 K | 4.930 M | -778.611 K | 7.447 M | -1.966 M | -7.780 M | |
| Net income | -11.334 M | 1.692 M | -1.249 M | -5.829 M | -6.338 M | -6.225 M | -8.164 M | -8.278 M | |
| Depreciation | 3.819 K | 3.816 K | 57.173 K | 22.839 K | 30.475 K | 26.656 K | 11.386 K | 22.839 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -225.000 K | -456.801 K | -75.000 K | -75.000 K | -105.000 K | -7.391 M | -75.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -7.401 M | -5.309 M | -73.605 K | 4.930 M | -778.611 K | 7.447 M | -1.966 M | -7.780 M |